Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether RNS60, in combination with budesonide, is
safe in mild to moderate asthmatics when taken by nebulization over a 28-day period, compared
to a 28-day control period.